ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $191,000 | +229.3% | 260,005 | +815.8% | 0.00% | – |
| Q4 2019 | $58,000 | -34.1% | 28,391 | -7.1% | 0.00% | – |
| Q3 2019 | $88,000 | -70.3% | 30,562 | +60.8% | 0.00% | -100.0% |
| Q4 2018 | $296,000 | -80.7% | 19,001 | -75.6% | 0.00% | -66.7% |
| Q3 2018 | $1,532,000 | +256.3% | 77,971 | +328.4% | 0.00% | +200.0% |
| Q3 2017 | $430,000 | +106.7% | 18,200 | +275.0% | 0.00% | 0.0% |
| Q4 2015 | $208,000 | -93.7% | 4,853 | -95.0% | 0.00% | -97.1% |
| Q3 2014 | $3,286,000 | – | 96,982 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |